APP and Alzheimer disease: Recent work has shown minimal exacerbation of AD-like pathology with a Hfd in the AppNL/NL knock-in mouse model of AD, suggesting that the overexpression of mutant APP, as in most AD mouse models, may also influence the impact of a Hfd19,54,63.